FDA Defies Panel, OKs Avastin for Breast Cancer

WASHINGTON (AP) - A drug made by Genentech received federal approval on Friday to treat breast cancer, a decision that could represent a major shift in standards for assessing the effectiveness of cancer medicines.

Going against the recommendation of its advisory panel, the Food and Drug Administration cleared Genentech's Avastin, which is already approved for treating lung and colon cancer, based on findings that it slowed tumor growth.

The agency has traditionally approved drugs for late-stage cancer if they extended, or improved the quality of, patients' lives. Avastin showed neither, according to Genentech's application.

Wall Street analysts believe FDA's Avastin decision opens the door for other cancer drugs to be approved for their tumor-shrinking capabilities - a trend that worries some health experts.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

-- This embed didnt make it to copy for story id = 4331703. -- This embed didnt make it to copy for story id = 4331703.
Join the Discussion
blog comments powered by Disqus
 
You Might Also Like...
See It, Share It
PHOTO: Director Wes Craven attends the screening of Life Itself at the ArcLight Cinemas, June 26, 2014, in Hollywood, Calif.
Paul Archuleta/FilmMagic/Getty Images
PHOTO: Kanye West accepts the Vanguard Award onstage during the 2015 MTV Video Music Awards at Microsoft Theater on August 30, 2015 in Los Angeles, California.
Christopher Polk/MTV1415/Getty Images
PHOTO: Russian President Vladimir Putin works out at Bocharov Ruchei residence in Sochi, Russia, Aug. 30, 2015.
Russian Presidential Press and Information Office/Anadolu Agency/Getty Images